Open AccessAn expert opinion of the Association of Cardiovascular Interventions and the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society related to the place of prasugrel in the prevention of cardiovascular events in patients with acute coronary syndromes
Author(s) -
Marcin Barylski,
Jacek Legutko,
Maciej Lesiak,
Stanisław Bartuś,
Artur Mamcarz,
Beata WożakowskaKapłon,
Marek Grygier,
Wojciech Wojakowski,
Adam Witkowski
Publication year - 2022
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2022.0006
Subject(s) - prasugrel , medicine , ticagrelor , clopidogrel , expert opinion , p2y12 , pharmacotherapy , intensive care medicine , acute coronary syndrome , randomized controlled trial , clinical trial , cardiology , myocardial infarction